Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
indomethacin aldo-keto reductase family 1 member c3 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 0.5 approved,investigational inhibitor
indomethacin aldo-keto reductase family 1 member c3 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.5 approved,investigational inhibitor
indomethacin interferon-induced, double-stranded rna-activated protein kinase small molecule NA drugbank Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inducer
indomethacin interferon-induced, double-stranded rna-activated protein kinase small molecule NA drugbank Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational inducer
indomethacin lactoylglutathione lyase small molecule NA drugbank Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational inhibitor
indomethacin lactoylglutathione lyase small molecule NA drugbank Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
indomethacin phospholipase a2, membrane associated small molecule NA drugbank Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational inhibitor
indomethacin phospholipase a2, membrane associated small molecule NA drugbank Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
indomethacin peroxisome proliferator-activated receptor alpha small molecule NA drugbank Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational agonist
indomethacin peroxisome proliferator-activated receptor alpha small molecule NA drugbank Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational agonist
indomethacin peroxisome proliferator-activated receptor gamma small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.04 approved,investigational activator,agonist
indomethacin peroxisome proliferator-activated receptor gamma small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 0.04 approved,investigational activator,agonist
indomethacin prostaglandin d2 receptor 2 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 0.37 approved,investigational agonist
indomethacin prostaglandin d2 receptor 2 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.37 approved,investigational agonist
indomethacin prostaglandin reductase 2 small molecule NA drugbank Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
indomethacin prostaglandin reductase 2 small molecule NA drugbank Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational inhibitor
indomethacin prostaglandin g/h synthase 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.33 approved,investigational inhibitor
indomethacin prostaglandin g/h synthase 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 0.33 approved,investigational inhibitor
indomethacin prostaglandin g/h synthase 2 small molecule Successful target TTD , drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 0.3 approved,investigational inhibitor
indomethacin prostaglandin g/h synthase 2 small molecule Successful target TTD , drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Patent ductus arteriosus[MeSHID:D004374]
Degenerative polyarthritis[MeSHID:D010003]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Body Fluids[MeSHID:D001826]
Chronic disease[MeSHID:D002908]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.3 approved,investigational inhibitor
click here to return to the previous page